1. A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families
- Author
-
Peelen, T., Vanvliet, M., Petrijbosch, A., Mieremet, R., Szabo, C., Vandenouweland, A. M. W., Hogervorst, F., Brohet, R., Ligtenberg, M. J. L., Teugels, E., Vanderluijt, R., Vanderhout, A. H., Gille, J. J. P., Pals, G., Jedema, I., Olmer, R., Vanleeuwen, I., Newman, B., Plandsoen, M., Vanderest, M., Brink, G., Hageman, S., Arts, P. J. W., Bakker, M. M., Willems, H. W., Vanderlooij, E., Neyns, B., Bonduelle, M., Jansen, R., Oosterwijk, J. C., Sijmons, R., Smeets, H. J. M., Vanasperen, C. J., Meijersheijboer, H., Klijn, J. G. M., Degreve, J., King, M. C., Menko, F. H., Brunner, H. G., Halley, D., Vanommen, G. J. B., Vasen, H. F. A., Cornelisse, C. J., Vantveer, L. J., Peter de Knijff, Bakker, E., Devilee, P., Clinical Genetics, Pathology, Medical Oncology, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Targeted Gynaecologic Oncology (TARGON), and Other departments
- Subjects
RAPID DETECTION ,GERMLINE MUTATIONS ,DNA ,Original Articles ,Tumor pathologie ,FREQUENCY ,CARRIERS ,PROTEIN TRUNCATION TEST ,SUSCEPTIBILITY GENE ,SDG 3 - Good Health and Well-being ,LINKAGE ,De rol van chromosoomafwijkingen en (anti-)oncogenen in humane tumoren ,The role of chromosomal aberrations and (anti-)oncogenes in human tumours ,Tumor pathology ,185DELAG ,GeneralLiterature_REFERENCE(e.g.,dictionaries,encyclopedias,glossaries) - Abstract
We have identified 79 mutations in BRCA1 in a set of 643 Dutch and 23 Belgian hereditary breast and ovarian cancer families collected either for research or for clinical diagnostic purposes. Twenty-eight distinct mutations have been observed, 18 of them not previously reported and 12 of them occurring more than once. Most conspicuously, a 2804delAA mutation has been found 19 times and has never been reported outside the Netherlands. A common haplotype spanning greater than or equal to 375 kb could be identified for each of the nine examined recurrent mutations, indicating the presence of multiple BRCA1 founder mutations in the Dutch population. The 2804delAA mutation has been estimated to have originated similar to 32 generations ago, No specific breast or ovarian cancer phenotype could be assigned to any of the common mutations, and the ovarian cancer incidence among 18 families with the 2804delAA mutation was heterogeneous.
- Published
- 1997